| Secondary |
| Ill-defined Disorder |
23.6% |
| Phobia |
15.2% |
| Product Used For Unknown Indication |
13.3% |
| Depression |
12.1% |
| Drug Use For Unknown Indication |
9.1% |
| Constipation |
5.5% |
| Bipolar Disorder |
4.8% |
| Drug Therapy |
4.2% |
| Arthritis |
3.6% |
| Colitis |
1.8% |
| Growth Hormone Deficiency |
1.2% |
| Malaise |
1.2% |
| Pain |
1.2% |
| Schizophrenia |
1.2% |
| Abdominal Pain |
0.6% |
| Delusional Disorder, Persecutory Type |
0.6% |
| Gastritis |
0.6% |
|
| Vision Blurred |
38.5% |
| Weight Decreased |
13.5% |
| Dry Mouth |
7.7% |
| Irritable Bowel Syndrome |
7.7% |
| Intentional Overdose |
5.8% |
| Withdrawal Syndrome |
5.8% |
| Sexual Dysfunction |
3.8% |
| Suicidal Ideation |
3.8% |
| Vomiting |
3.8% |
| Constipation |
1.9% |
| Depression |
1.9% |
| Inflammation |
1.9% |
| Pancreatitis Necrotising |
1.9% |
| Suicide Attempt |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.7% |
| Depression |
20.4% |
| Drug Use For Unknown Indication |
9.4% |
| Schizophrenia |
6.3% |
| Constipation |
3.6% |
| Insomnia |
3.1% |
| Psychotic Disorder |
2.2% |
| Benign Prostatic Hyperplasia |
1.6% |
| Pain |
1.6% |
| Bipolar Disorder |
1.3% |
| Depressed Mood |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Anxiety |
0.9% |
| Arthritis |
0.7% |
| Blood Pressure |
0.7% |
| Hypertension |
0.7% |
| Memory Impairment |
0.7% |
| Mood Altered |
0.7% |
| Schizophrenia, Paranoid Type |
0.7% |
| Agitation |
0.5% |
|
| Priapism |
13.0% |
| Contusion |
11.3% |
| Vomiting |
11.3% |
| Withdrawal Syndrome |
8.7% |
| Tremor |
7.8% |
| Glomerular Filtration Rate Decreased |
7.0% |
| Pain In Extremity |
5.2% |
| Hyperhidrosis |
4.3% |
| Urinary Tract Infection |
4.3% |
| Weight Decreased |
4.3% |
| Transient Ischaemic Attack |
3.5% |
| Vertigo |
3.5% |
| Suicidal Ideation |
2.6% |
| Urinary Incontinence |
2.6% |
| Antipsychotic Drug Level Above Therapeutic |
1.7% |
| Cerebrovascular Accident |
1.7% |
| Myocardial Infarction |
1.7% |
| Myocardial Ischaemia |
1.7% |
| Neutrophil Count Increased |
1.7% |
| Noonan Syndrome |
1.7% |
|
| Interacting |
| Psychotic Disorder |
40.0% |
| Analgesic Effect |
20.0% |
| Depression |
20.0% |
| Insomnia |
20.0% |
|
| Transient Ischaemic Attack |
100.0% |
|
